About SK bioscience
SK bioscience is a company based in Seongnam-si (South Korea) founded in 2018.. The company has 1,020 employees as of December 31, 2024. SK bioscience has completed 1 acquisition, including IDT Biologika. SK bioscience operates in a competitive market with competitors including AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
- Headquarter Seongnam-si, South Korea
- Employees 1020 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sk Bioscience Co.,Ltd.
-
Annual Revenue
$181.42 M (USD)-27.59as on Dec 31, 2024
-
Net Profit
$-36.53 M (USD)-341.43as on Dec 31, 2024
-
EBITDA
$-80.67 M (USD)-1258.01as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
1020
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SK bioscience
SK bioscience is a publicly listed company on the KRX with ticker symbol 302440 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of SK bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by SK bioscience
SK bioscience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include IDT Biologika. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
1921 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SK bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sk Bioscience Comparisons
Competitors of SK bioscience
SK bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
India's leading healthcare products distribution platform
|
|
| domain | founded_year | HQ Location |
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
|
|
| domain | founded_year | HQ Location |
Diversified drugs are distributed by Renee in the United States.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sk Bioscience
Frequently Asked Questions about SK bioscience
When was SK bioscience founded?
SK bioscience was founded in 2018.
Where is SK bioscience located?
SK bioscience is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
How many employees does SK bioscience have?
As of Dec 31, 2024, the latest employee count at SK bioscience is 1,020.
What is the annual revenue of SK bioscience?
Annual revenue of SK bioscience is $181.42M as on Dec 31, 2024.
What does SK bioscience do?
SK bioscience was founded in 2018 and is headquartered in Seongnam-si, South Korea. Operations center on the vaccine sector, where routine vaccines and COVID-19 candidates are developed and manufactured. Expertise in research, development, and production processes is applied to support these activities. The companys domain, skbioscience.com, facilitates information on its vaccine portfolio and advancements.
Who are the top competitors of SK bioscience?
SK bioscience's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
Is SK bioscience publicly traded?
Yes, SK bioscience is publicly traded on KRX under the ticker symbol 302440.
How many acquisitions has SK bioscience made?
SK bioscience has made 1 acquisition, including IDT Biologika.
What is SK bioscience's ticker symbol?
The ticker symbol of SK bioscience is 302440 on KRX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.